These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25686145)

  • 1. Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy.
    Park SJ; Jo KW; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Park SH; Shim TS
    Int J Tuberc Lung Dis; 2015 Mar; 19(3):342-8. PubMed ID: 25686145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of latent tuberculous infection among health care workers at a tertiary hospital in Korea.
    Lee EH; Kim SJ; Ha EJ; Park ES; Choi JY; Leem AY; Kim SY; Park MS; Kim YS; Kang YA
    Int J Tuberc Lung Dis; 2018 Nov; 22(11):1336-1343. PubMed ID: 30355414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Status of Latent Tuberculosis Infection Treatment Among Pediatric Patients in Korea: Prescription and Treatment Completion.
    Kim Y; Bae KS; Choi UY; Han SB; Kim JH
    J Korean Med Sci; 2024 Feb; 39(7):e64. PubMed ID: 38412611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.
    Lardizabal A; Passannante M; Kojakali F; Hayden C; Reichman LB
    Chest; 2006 Dec; 130(6):1712-7. PubMed ID: 17166986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area.
    Bonfiglioli KR; Ribeiro AC; Moraes JC; Saad CG; Souza FH; Calich AL; Bonfa E; Laurindo IM
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):905-11. PubMed ID: 25199003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completion rate of latent tuberculosis infection treatment in patients aged 65 years and older.
    Noh CS; Kim HI; Choi H; Kim Y; Kim CH; Choi JH; Hyun IG; Baek MS
    Respir Med; 2019 Oct; 157():52-58. PubMed ID: 31522030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.
    Jo KW; Hong Y; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2013 Nov; 107(11):1797-802. PubMed ID: 24029000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of short-term treatment with isoniazid and rifampicin for latent tuberculosis infection in lung transplant candidates.
    Guirao-Arrabal E; Santos F; Redel J; Vaquero JM; Torre-Cisneros J
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequacy of initiating TNF antagonists within 3 weeks of starting latent tuberculosis infection treatment in patients with immune-mediated inflammatory diseases.
    Yang JY; Jo KW; Hong S; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Park SH; Shim TS
    Infect Dis (Lond); 2016 Apr; 48(4):293-298. PubMed ID: 26667845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'either test positive' strategy for latent tuberculous infection before anti-tumour necrosis factor treatment.
    Jung YJ; Lee JY; Jo KW; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):428-34. PubMed ID: 24670697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates.
    Knoll BM; Nog R; Wu Y; Dhand A
    Infection; 2017 Jun; 45(3):335-339. PubMed ID: 28276008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis.
    Han SS; Lee SJ; Yim JJ; Song JH; Lee EH; Kang YA
    PLoS One; 2019; 14(9):e0222810. PubMed ID: 31536577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic.
    Gaensbauer J; Aiona K; Haas M; Reves R; Young J; Belknap R
    Pediatr Infect Dis J; 2018 Mar; 37(3):224-228. PubMed ID: 28777204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved treatment completion with shorter treatment regimens for latent tuberculous infection.
    Macaraig MM; Jalees M; Lam C; Burzynski J
    Int J Tuberc Lung Dis; 2018 Nov; 22(11):1344-1349. PubMed ID: 30355415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient choice promotes adherence in preventive treatment for latent tuberculosis.
    Rennie TW; Bothamley GH; Engova D; Bates IP
    Eur Respir J; 2007 Oct; 30(4):728-35. PubMed ID: 17626113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [10 years of innovation in the treatment of latent tuberculosis infection: a comparison between standard and short course therapies in directly observed therapy].
    López G; Wood M; Ayesta FJ
    Rev Esp Sanid Penit; 2011; 13(1):3-14. PubMed ID: 21484073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active tuberculosis risk with tumor necrosis factor inhibitors after treating latent tuberculosis.
    Kwon M; Sung M; Kwon YJ; Song YG; Lee SW; Park MC; Park YB; Lee SK; Song JJ
    J Clin Rheumatol; 2014 Mar; 20(2):68-73. PubMed ID: 24561408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.